• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天花病毒生物学。

Biology of Variola Virus.

机构信息

Department of Biotechnology, Cochin University of Science and Technology, Cochin, Kerala, 682022, India.

Institute of Advanced Virology, Thonnakkal, Trivandrum, Kerala, 695317, India.

出版信息

Adv Exp Med Biol. 2024;1451:139-149. doi: 10.1007/978-3-031-57165-7_9.

DOI:10.1007/978-3-031-57165-7_9
PMID:38801576
Abstract

Variola virus is an anthroponotic agent that belongs to the orthopoxvirus family. It is an etiological agent of smallpox, an ancient disease that caused massive mortality of human populations. Twentieth century has witnessed the death of about 300 million people due to the unavailability of an effective vaccine. Early detection is the primary strategy to prevent an outbreak of smallpox. Variola virus forms the characteristic pus-filled pustules and centrifugal rash distribution in the infected patients while transmission occurs mainly through respiratory droplets during the early stage of infection. No antiviral drugs are approved for variola virus till date. Generation of first-generation vaccines helped in the eradication of smallpox which was declared by the World Health Organization.

摘要

天花病毒是一种人兽共患病原体,属于正痘病毒科。它是天花的病原体,天花是一种古老的疾病,曾导致大量人口死亡。二十世纪,由于缺乏有效的疫苗,约有 3 亿人因此死亡。早期发现是预防天花爆发的主要策略。感染天花的患者会出现特征性的充满脓液的脓疱和离心性皮疹分布,而传播主要发生在感染早期的呼吸道飞沫中。迄今为止,还没有批准用于天花病毒的抗病毒药物。第一代疫苗的产生有助于世界卫生组织宣布的天花根除。

相似文献

1
Biology of Variola Virus.天花病毒生物学。
Adv Exp Med Biol. 2024;1451:139-149. doi: 10.1007/978-3-031-57165-7_9.
2
Poxvirus viability and signatures in historical relics.历史遗迹中的痘病毒生存能力及特征
Emerg Infect Dis. 2014 Feb;20(2):177-84. doi: 10.3201/eid2002/131098.
3
Smallpox vaccines: targets of protective immunity.天花疫苗:保护性免疫的靶标。
Immunol Rev. 2011 Jan;239(1):8-26. doi: 10.1111/j.1600-065X.2010.00975.x.
4
[Smallpox].
Nihon Naika Gakkai Zasshi. 2004 Nov 10;93(11):2316-22.
5
[How serious is the smallpox threat?].[天花威胁有多严重?]
Dtsch Med Wochenschr. 2014 Jul;139(30):1506-7. doi: 10.1055/s-0034-1374701.
6
[We should be prepared to smallpox re-emergence.].我们应该为天花的再次出现做好准备。
Vopr Virusol. 2019;64(5):206-214. doi: 10.36233/0507-4088-2019-64-5-206-214.
7
Smallpox in the Post-Eradication Era.《消灭天花后的天花》
Viruses. 2020 Jan 24;12(2):138. doi: 10.3390/v12020138.
8
Smallpox: gone but not forgotten.天花:虽已消失,但仍被铭记。
Infection. 1998 Sep-Oct;26(5):263-9. doi: 10.1007/BF02962244.
9
Looking back at smallpox.回顾天花
Clin Infect Dis. 2004 Mar 15;38(6):882-9. doi: 10.1086/381976. Epub 2004 Mar 1.
10
[The smallpox vaccines and the definitive destruction of the last virus strains].[天花疫苗与最后一批病毒毒株的彻底销毁]
Med Clin (Barc). 2011 Sep 17;137(7):308-10. doi: 10.1016/j.medcli.2011.04.004. Epub 2011 May 24.

引用本文的文献

1
Mpox virus: virology, molecular epidemiology, and global public health challenges.猴痘病毒:病毒学、分子流行病学及全球公共卫生挑战
Front Microbiol. 2025 Jul 17;16:1624110. doi: 10.3389/fmicb.2025.1624110. eCollection 2025.
2
Exploring monkeypox virus antibody levels: insights from human immunological research.探索猴痘病毒抗体水平:来自人体免疫学研究的见解
Virol J. 2025 May 31;22(1):175. doi: 10.1186/s12985-025-02748-0.

本文引用的文献

1
A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.一项多中心、开放标签、对照的II期研究,旨在评估MVA天花疫苗(IMVAMUNE)在18至40岁诊断为特应性皮炎的受试者中的安全性和免疫原性。
PLoS One. 2015 Oct 6;10(10):e0138348. doi: 10.1371/journal.pone.0138348. eCollection 2015.
2
Mapping vaccinia virus DNA replication origins at nucleotide level by deep sequencing.通过深度测序在核苷酸水平上绘制痘苗病毒DNA复制起点图谱。
Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):10908-13. doi: 10.1073/pnas.1514809112. Epub 2015 Aug 18.
3
Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates.
在非人类灵长类动物中,比较基于基因的天花疫苗与 MVA。
PLoS One. 2012;7(7):e42353. doi: 10.1371/journal.pone.0042353. Epub 2012 Jul 31.
4
Poxvirus host cell entry.痘病毒宿主细胞进入。
Curr Opin Virol. 2012 Feb;2(1):20-7. doi: 10.1016/j.coviro.2011.11.007. Epub 2011 Dec 27.
5
Inhibition of poxvirus spreading by the anti-tumor drug Gefitinib (Iressa).抗肿瘤药物吉非替尼(易瑞沙)抑制痘病毒的传播。
Antiviral Res. 2011 Jan;89(1):64-70. doi: 10.1016/j.antiviral.2010.11.006. Epub 2010 Nov 19.
6
Variola and monkeypox viruses utilize conserved mechanisms of virion motility and release that depend on abl and SRC family tyrosine kinases.天花病毒和猴痘病毒利用病毒运动和释放的保守机制,这些机制依赖于abl 和 SRC 家族酪氨酸激酶。
J Virol. 2011 Jan;85(1):21-31. doi: 10.1128/JVI.01814-10. Epub 2010 Oct 20.
7
Modulation of the host immune response by cowpox virus.牛痘病毒对宿主免疫反应的调节。
Microbes Infect. 2010 Nov;12(12-13):900-9. doi: 10.1016/j.micinf.2010.07.007. Epub 2010 Jul 29.
8
A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge.一种基于蛋白质的天花疫苗可保护非人类灵长类动物免受致命猴痘病毒的挑战。
Vaccine. 2010 Sep 14;28(40):6627-36. doi: 10.1016/j.vaccine.2010.07.030. Epub 2010 Jul 24.
9
A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteers.一项评估新型细胞培养痘苗疫苗 CJ-50300 在健康志愿者中的疗效和安全性的随机、双盲、对照临床试验。
Vaccine. 2010 Aug 16;28(36):5845-9. doi: 10.1016/j.vaccine.2010.06.063. Epub 2010 Jun 30.
10
Vaccinia virus strains use distinct forms of macropinocytosis for host-cell entry.牛痘病毒株利用不同形式的巨胞饮作用进入宿主细胞。
Proc Natl Acad Sci U S A. 2010 May 18;107(20):9346-51. doi: 10.1073/pnas.1004618107. Epub 2010 May 3.